| Print
SARTORIUS STED BIO (DIM)
SARTORIUS STED BIOThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa,15% from Asia excluding China, and 8% from China.
Address
Weender Landstrasse 94-108
Goettingen
FRA
37075
Telephone
+49 5513083232
Forecast key dates
| Name | Key Date |
|---|---|
| Sartorius Stedim Biotech SA Third Quarter Earnings Results for 2026 | 2026-10-16T00:00:00 |
| Sartorius Stedim Biotech SA Third Quarter Earnings Conference Call for 2026 | 2026-10-16T00:00:00 |
| Sartorius Stedim Biotech SA Second Quarter Earnings Results for 2026 | 2026-07-22T00:00:00 |
| Sartorius Stedim Biotech SA Second Quarter Earnings Conference Call for 2026 | 2026-07-22T00:00:00 |
| Sartorius Stedim Biotech SA First Quarter Earnings Conference Call for 2026 | 2026-04-16T13:00:00 |
| Sartorius Stedim Biotech SA First Quarter Earnings Results for 2026 | 2026-04-16T00:00:00 |
| Sartorius Stedim Biotech SA Annual General Meeting for 2025 | 2026-03-25T13:00:00 |
| Sartorius Stedim Biotech SA Annual Report for 2025 | 2026-02-17T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Sartorius Stedim Biotech SA Third Quarter Earnings Results for 2025 | 2025-10-16T00:00:00 |
| Sartorius Stedim Biotech SA Third Quarter Earnings Conference Call for 2025 | 2025-10-16T00:00:00 |
| Sartorius Stedim Biotech SA Second Quarter Earnings Result for 2025 | 2025-07-22T00:00:00 |
| Sartorius Stedim Biotech SA Second Quarter Earnings Conference Call for 2025 | 2025-07-22T00:00:00 |
| Sartorius Stedim Biotech SA First Quarter Earnings Conference Call for 2025 | 2025-04-16T13:00:00 |
| Sartorius Stedim Biotech SA First Quarter Earnings Results for 2025 | 2025-04-16T00:00:00 |
| Sartorius Stedim Biotech SA Annual General Meeting for 2024 | 2025-03-25T13:00:00 |
| Sartorius Stedim Biotech SA Annual Report for 2024 | 2025-02-17T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.